purpose present initial experience preliminary clinical results patients treated mainly proton irradiation newly developed proton therapy facility shizuoka cancer center materials methods reviewed NUMBER patients underwent proton therapy july NUMBER december NUMBER NUMBER patients NUMBER head neck malignancies NUMBER cell lung cancers NUMBER hepatocellular carcinomas NUMBER prostate cancers NUMBER malignant tumors results patients experienced grade acute morbidities skin mucosa temporary grade reaction observed high dose area response rates NUMBER h n malignancies NUMBER nsclc NUMBER hcc psa evaluation patients prostate cancer revealed high rate complete response conclusion efficacy safety proton therapy shizuoka cancer center demonstrated patients cancer locally advanced disease non small NUMBER NUMBER nci ctc NUMBER NUMBER early stage